Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers

PHASE3TerminatedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2008

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Dermal - Living Skin Replacement (Dermal - LSR)

Trial Locations (12)

11042

North Shore Diabetic and Endocrine Associates, New Hyde Park

19601

Center for Advanced Wound Care, Reading

33143

Doctors Research Network, South Miami

44195

The Learner Research Centre, Department of Orthopaedic Surgery. The Cleveland Clinic Foundation, 9500 Euclid Ave. A40, Cleveland

60016

Weil Foot and Ankle Institute, Des Plaines

60141

Hines VA Hospital, Hines

60714

National Center for Lower Limb Preservation, Niles

85723

Southern Arizona Veterans Administration Health Care System, 3601 S. 6th Avenue (2-112), Tuscon

92116

San Diego Research Center 4452 Park Boulevard Suite 210, San Diego, San Diego

95655

Veterans Affairs Northern Health Care System, Sacramento VA Medical Center at Mather, Mather

02118

Foot Care Vascular and Endovascular Specialists of Boston Medical Center, Boston

02215

Joslin-Beth Israel Deaconess Foot Center, Division of Podiatry, 185 Pilgrim Road, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ApoPharma

INDUSTRY

NCT00387101 - Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter